Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile Infection

Author:

Haddad Natalie S.1ORCID,Nozick Sophia1,Kim Geena1,Ohanian Shant1,Kraft Colleen S.23ORCID,Rebolledo Paulina A.43ORCID,Wang Yun25,Wu Hao6,Bressler Adam7,Le Sang Nguyet Thi8,Kuruvilla Merin8,Runnstrom Martin C.8,Ramonell Richard P.8,Cannon L. Edward1,Lee F. Eun-Hyung18,Daiss John L.1ORCID

Affiliation:

1. MicroB-plex, Inc., Atlanta, GA, USA

2. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA

3. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA

4. Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA

5. Department of Pathology and Laboratory Medicine, Grady Memorial Hospital, Atlanta, GA, USA

6. Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA

7. Infectious Disease Specialists of Atlanta, Decatur, GA, USA

8. Pulmonary, Allergy, Critical Care & Sleep Medicine, Emory University, Atlanta, GA, USA

Abstract

Within 8 weeks of primary Clostridioides difficile infection (CDI), as many as 30% of patients develop the recurrent disease with the associated risks of multiple relapses, morbidity, and economic burden. There are no clear clinical correlates or validated biomarkers that can predict recurrence during primary infection.

Funder

Centers for Disease Control and Prevention

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3